These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 2588105)

  • 21. Direct injection of calcitriol or its analog improves abnormal gene expression in the hyperplastic parathyroid gland in uremia.
    Shiizaki K; Fukagawa M; Yuan Q; Hatamura I; Nii-Kono T; Saji F; Shigematsu T; Akizawa T
    Am J Nephrol; 2008; 28(1):59-66. PubMed ID: 17901691
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo regulation of chromogranin A messenger ribonucleic acid in the parathyroid by 1,25-dihydroxyvitamin D: studies in normal rats and in chronic renal insufficiency.
    Soliman E; Canaff L; Fox J; Hendy GN
    Endocrinology; 1997 Jun; 138(6):2596-600. PubMed ID: 9165053
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary parathyroid gland hyperplasia in dogs: six cases (1982-1991).
    DeVries SE; Feldman EC; Nelson RW; Kennedy PC
    J Am Vet Med Assoc; 1993 Apr; 202(7):1132-6. PubMed ID: 8473230
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of parathyroid gland hyperplasia without uremia: role of dietary calcium and phosphate.
    Canalejo A; Canalejo R; Rodriguez ME; Martinez-Moreno JM; Felsenfeld AJ; Rodríguez M; Almaden Y
    Nephrol Dial Transplant; 2010 Apr; 25(4):1087-97. PubMed ID: 19934096
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Parathyroid acidosis in uraemia.
    Muldowney FP; Donohoe JF; Carroll DV; Powell D; Freaney R
    Q J Med; 1972 Jul; 41(163):321-42. PubMed ID: 5072056
    [No Abstract]   [Full Text] [Related]  

  • 26. Regulation of parathyroid cell gene expression in experimental uremia.
    Shvil Y; Naveh-Many T; Barach P; Silver J
    J Am Soc Nephrol; 1990 Jul; 1(1):99-104. PubMed ID: 2104257
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relation between parathyroid cell mass and plasma calcium concentration in normal and uremic subjects. A theoretical model with an analysis of the concept of autonomy, and speculations on the mechanism of parathyroid hyperplasia.
    Parfitt AM
    Arch Intern Med; 1969 Sep; 124(3):269-73. PubMed ID: 5806040
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical experience with percutaneous ethanol injection therapy in hemodialysis patients with renal hyperparathyroidism.
    Nakamura M; Fuchinoue S; Teraoka S
    Am J Kidney Dis; 2003 Oct; 42(4):739-45. PubMed ID: 14520624
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medical management of secondary hyperparathyroidism in uremia.
    Drüeke TB
    Am J Med Sci; 1999 Jun; 317(6):383-9. PubMed ID: 10372838
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cinacalcet suppresses calcification of the aorta and heart in uremic rats.
    Kawata T; Nagano N; Obi M; Miyata S; Koyama C; Kobayashi N; Wakita S; Wada M
    Kidney Int; 2008 Nov; 74(10):1270-7. PubMed ID: 18813289
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel, selective vitamin D analog suppresses parathyroid hormone in uremic animals and postmenopausal women.
    Zella JB; Plum LA; Plowchalk DR; Potochoiba M; Clagett-Dame M; DeLuca HF
    Am J Nephrol; 2014; 39(6):476-83. PubMed ID: 24854296
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of 19-Nor-1,25-(OH)2D2 in the prevention and treatment of hyperparathyroid bone disease in experimental uremia.
    Slatopolsky E; Cozzolino M; Lu Y; Finch J; Dusso A; Staniforth M; Wein Y; Webster J
    Kidney Int; 2003 Jun; 63(6):2020-7. PubMed ID: 12753289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduced parathyroid vitamin D receptor messenger ribonucleic acid levels in primary and secondary hyperparathyroidism.
    Carling T; Rastad J; Szabó E; Westin G; Akerström G
    J Clin Endocrinol Metab; 2000 May; 85(5):2000-3. PubMed ID: 10843188
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Parathyroid function after kidney allografting.
    Tajima A; Ishikawa A; Ohta N; Suzuki K; Kawabe K; Aso Y
    Transplant Proc; 1996 Jun; 28(3):1629-30. PubMed ID: 8658814
    [No Abstract]   [Full Text] [Related]  

  • 35. p21(WAF1) and transforming growth factor-alpha mediate dietary phosphate regulation of parathyroid cell growth.
    Dusso AS; Pavlopoulos T; Naumovich L; Lu Y; Finch J; Brown AJ; Morrissey J; Slatopolsky E
    Kidney Int; 2001 Mar; 59(3):855-65. PubMed ID: 11231340
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Correlation of tumor weight and typical pathologic laboratory parameters in primary and secondary hyperparathyroidism].
    Wagner PK; Rothmund M
    Langenbecks Arch Chir; 1983; 360(2):133-9. PubMed ID: 6633086
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Parathyroid growth and suppression in renal failure.
    Lewin E; Huan J; Olgaard K
    Semin Dial; 2006; 19(3):238-45. PubMed ID: 16689976
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A model of reversible uremia employing isogenic kidney transplantation in the rat. Reversibility of secondary hyperparathyroidism.
    Lewin E; Colstrup H; Pless V; Ladefoged J; Olgaard K
    Scand J Urol Nephrol; 1993; 27(1):115-20. PubMed ID: 8493458
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum osteocalcin in primary hyperparathyroidism: short-term effect of surgery.
    Minisola S; Scarnecchia L; Scarda A; Bigi F; Tabolli S; Valtorta C; Mazzuoli G
    Miner Electrolyte Metab; 1988; 14(4):201-7. PubMed ID: 3264876
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Calcium-dependent release of N-terminal fragments and intact immunoreactive parathyroid hormone by human pathological parathyroid tissue in vitro.
    el-Hajj Fuleihan G; Chen CJ; Rivkees SA; Marynick SP; Stock J; Pallotta JA; Brown EM
    J Clin Endocrinol Metab; 1989 Oct; 69(4):860-7. PubMed ID: 2778039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.